Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

2003 • 7,470 citations

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

2004 • 4,872 citations

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma

2003 • 2,871 citations

Regulatory T cells, tumour immunity and immunotherapy

2006 • 2,009 citations

Immunosuppressive networks in the tumour environment and their therapeutic relevance

2005 • 1,990 citations

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients

1999 • 985 citations

Malignant mesothelioma

2005 • 640 citations

A Proposed New International TNM Staging System for Malignant Pleural Mesothelioma

1995 • 602 citations

Induction of Tumor Cell Apoptosis In Vivo Increases Tumor Antigen Cross-Presentation, Cross-Priming Rather than Cross-Tolerizing Host Tumor-Specific CD8 T Cells

2003 • 441 citations

Application of Mesothelin Immunostaining in Tumor Diagnosis

2003 • 367 citations

Tumor-infiltrating T lymphocytes: friends or foes?

2006 • 282 citations

Neoadjuvant Chemotherapy Followed by Extrapleural Pneumonectomy in Malignant Pleural Mesothelioma

2004 • 244 citations

Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma

2003 • 216 citations

Phase I to II Study of Pleurectomy/Decortication and Intraoperative Intracavitary Hyperthermic Cisplatin Lavage for Mesothelioma

2006 • 215 citations

Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis

2002 • 193 citations

Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses

2006 • 155 citations

A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma

2003 • 133 citations

Intrapleural administration of interleukin-2 for the treatment of patients with malignant pleural mesothelioma

1998 • 123 citations

Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma

2005 • 120 citations

Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion

2001 • 81 citations

Phase II Study of a Liposome-Entrapped Cisplatin Analog (L-NDDP) Administered Intrapleurally and Pathologic Response Rates in Patients With Malignant Pleural Mesothelioma

2005 • 79 citations

Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma

2006 • 78 citations

Combined systemic chemoimmunotherapy in advanced diffuse malignant mesothelioma. Report of a phase I-II study of weekly cisplatin/interferon alfa-2a.

1996 • 72 citations

Lymphocytic infiltration of pleural mesothelioma and its significance for survival.

1982 • 68 citations

Intrapleural Infusion of Activated Macrophages and γ-Interferon in Malignant Pleural Mesothelioma

2002 • 60 citations

Combined regimen of cisplatin, doxorubicin, and ?-2b interferon in the treatment of advanced malignant pleural mesothelioma

2001 • 52 citations

Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: The Memorial Sloan-Kettering experience

2005 • 45 citations